Strategic Blueprint’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,299
Closed -$238K – 688
2026
Q2
$238K Buy
+2,299
New +$205K 0.01% 628
2023
Q2
– Sell
-44,377
Closed -$3.3M – 544
2023
Q1
$3.3M Sell
44,377
-2,168
-5% -$182K 0.34% 71
2022
Q4
$4.34M Buy
46,545
+1,944
+4% +$188K 0.5% 43
2022
Q3
$4.25M Buy
44,601
+11,612
+35% +$1.15M 0.51% 42
2022
Q2
$3.06M Buy
+32,989
New +$3.22M 0.38% 71
2021
Q3
– Sell
-551
Closed -$46K – 582
2021
Q2
$46K Buy
+551
New +$45.1K 0.01% 640
2020
Q2
– Sell
-24,140
Closed -$1.43M – 172
2020
Q1
$1.43M Sell
24,140
-1,134
-4% -$75.7K 0.84% 44
2019
Q4
$1.88M Sell
25,274
-1,470
-5% -$103K 1.29% 29
2019
Q3
$1.69M Sell
26,744
-627
-2% -$37.2K 1.27% 28
2019
Q2
$1.49M Buy
27,371
+4,906
+22% +$264K 1.27% 31
2019
Q1
$1.21M Buy
+22,465
New +$1.39M 1.1% 35

Other funds holding CVS

Strategic Blueprint's CVS Position: Q3 2026 in Review

Strategic Blueprint sold out of CVS Health (CVS) in Q3 2026, closing a stake of 2,299 shares — an estimated $238K sold.

Strategic Blueprint first reported a position in CVS in Q1 2019 and held it in 11 quarters. The position peaked at $4.34M in Q4 2022. 1,997 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Strategic Blueprint reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
  • Strategic Blueprint sold 2,299 CVS Health shares in Q3 2026, an estimated $238K.
  • Strategic Blueprint first reported a position in CVS Health in Q1 2019 and held it in 11 quarters.
  • Strategic Blueprint's CVS Health position peaked at $4.34M in Q4 2022.
  • 1,997 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Strategic Blueprint's 13F filing for Q3 2026, filed 22 Oct 2026.